Publication: 536

MYC protein expression and copy number anomalies in early-stage HER2+ breast cancer in context of the NCCTG adjuvant trial, N9831.
   Google Scholar   
Citation:
Molecular Markers in Cancer abstr 66
Meeting Instance:
ASCO MM 2010
Year:
2010
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
162   1056  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                   
Networks:
 
Study
NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: